v3.25.4
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Class A and Class B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income/(Loss)
Accumulated Deficit
Non- Controlling Interest
Balance beginning (in shares) at Dec. 31, 2022   604,674        
Balance beginning at Dec. 31, 2022 $ 305,035 $ 59 $ 2,213,603 $ 671 $ (1,908,307) $ (991)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares) 10,670 10,670        
Issuance of common stock upon exercise of stock options $ 23,749 $ 2 23,747      
Issuance of common stock under Employee Stock Purchase Plan (in shares)   1,065        
Issuance of common stock under Employee Stock Purchase Plan 29,629   29,629      
Vesting of restricted stock units and performance stock units (in shares)   14,812        
Stock-based compensation expense 867,967   867,967      
Other comprehensive income/(loss) 1,183     865   318
Net loss (1,158,937)       (1,151,946) (6,991)
Balance ending (in shares) at Dec. 31, 2023   631,221        
Balance ending at Dec. 31, 2023 $ 68,626 $ 61 3,134,946 1,536 (3,060,253) (7,664)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares) 12,498 12,498        
Issuance of common stock upon exercise of stock options $ 34,410 $ 1 34,409      
Issuance of common stock under Employee Stock Purchase Plan (in shares)   1,530        
Issuance of common stock under Employee Stock Purchase Plan 35,767   35,767      
Vesting of restricted stock units and performance stock units (in shares)   21,170        
Stock-based compensation expense 1,015,794   1,015,794      
Other comprehensive income/(loss) (5,329)     (5,431)   102
Net loss $ (940,614)       (935,384) (5,230)
Balance ending (in shares) at Dec. 31, 2024 666,419 666,419        
Balance ending at Dec. 31, 2024 $ 208,654 $ 62 4,220,916 (3,895) (3,995,637) (12,792)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares) 18,266 18,266        
Issuance of common stock upon exercise of stock options $ 51,018 $ 2 51,016      
Issuance of common stock under Employee Stock Purchase Plan (in shares)   1,448        
Issuance of common stock under Employee Stock Purchase Plan 37,623   37,623      
Vesting of restricted stock units and performance stock units (in shares)   22,226        
Stock-based compensation expense 1,129,004   1,129,004      
Other comprehensive income/(loss) 20,299     20,450   (151)
Net loss $ (1,071,618)       (1,065,057) (6,561)
Balance ending (in shares) at Dec. 31, 2025 708,359 708,359        
Balance ending at Dec. 31, 2025 $ 374,980 $ 64 $ 5,438,559 $ 16,555 $ (5,060,694) $ (19,504)